ARTICLE | Clinical News
VioQuest preclinical data
January 28, 2008 8:00 AM UTC
In vitro VQD-002, a tricyclic nucleoside that inhibits Akt phosphorylation, reduced cancer cell survival with or without cisplatin. Also, the microRNA miR-214 activated the Akt pathway and induced ova...